• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ocular Therapeutix, Inc. - Common Stock (NQ:OCUL)

11.82 -0.32 (-2.64%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,499,117
Open 12.08
Bid (Size) 11.75 (200)
Ask (Size) 11.85 (200)
Prev. Close 12.14
Today's Range 11.60 - 12.19
52wk Range 5.785 - 16.44
Shares Outstanding 157,749,490
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Ocular Therapeutix (NASDAQ:OCUL) Surprises With Q3 CY2025 Sales
January 02, 2026
Ophthalmology biopharmaceutical company Ocular Therapeutix (NASDAQ:OCUL) reported Q3 CY2025 results topping the market’s revenue expectations, but sales fell by 5.7% year on year to $14.54 million. Its... 
Via StockStory
Topics Artificial Intelligence
News headline image
Ocular Therapeutix Stock Skyrockets On Faster FDA Path For Vision Drug ↗
December 08, 2025
Ocular Therapeutix Inc (NASDAQ: OCUL) stock surged after announcing plans to expedite FDA submission for its wet AMD treatment. 
Via Benzinga

Performance

YTD
N/A
N/A
1 Month
-6.0%
-6.0%
3 Month
+7.7%
+7.7%
6 Month
+23.0%
+23.0%
1 Year
+33.1%
+33.1%

More News

Read More
News headline image
OCULAR THERAPEUTIX INC (NASDAQ:OCUL) Reports Mixed Q3 2025 Results with Narrower-Than-Expected Loss ↗
November 04, 2025
Via Chartmill
News headline image
Earnings Scheduled For November 4, 2025 ↗
November 04, 2025
Via Benzinga
News headline image
Eli Lilly To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
October 08, 2025
Via Benzinga
News headline image
Earnings Scheduled For August 5, 2025 ↗
August 05, 2025
Via Benzinga
News headline image
What's Next: Ocular Therapeutix's Earnings Preview ↗
August 04, 2025
Via Benzinga
News headline image
Demystifying Ocular Therapeutix: Insights From 7 Analyst Reviews ↗
May 29, 2025
Via Benzinga
News headline image
Expert Outlook: Ocular Therapeutix Through The Eyes Of 4 Analysts ↗
October 01, 2025
Via Benzinga
News headline image
This Broadcom Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
September 15, 2025
Via Benzinga
News headline image
OCUL Sales Drop 18% ↗
August 05, 2025
Via The Motley Fool
News headline image
OCULAR THERAPEUTIX INC (NASDAQ:OCUL) Reports Mixed Q2 2025 Earnings Amid Clinical Progress ↗
August 05, 2025
Via Chartmill
News headline image
Carnival Posts Better-Than-Expected Earnings, Joins Liminatus Pharma, Coinbase Global, Uber And Other Big Stocks Moving Higher On Tuesday ↗
June 24, 2025
Via Benzinga
News headline image
Earnings Scheduled For May 5, 2025 ↗
May 05, 2025
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
May 20, 2025
Via Benzinga
News headline image
Analyst Expectations For Ocular Therapeutix's Future ↗
May 06, 2025
Via Benzinga
News headline image
Ocular Therapeutix (OCUL) Stock Drops 13% After Q1 Earnings ↗
May 05, 2025
Via Benzinga
News headline image
Expert Outlook: Ocular Therapeutix Through The Eyes Of 5 Analysts ↗
April 08, 2025
Via Benzinga
News headline image
This Weyerhaeuser Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗
April 08, 2025
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About Ocular Therapeutix ↗
March 18, 2025
Via Benzinga
News headline image
Why Ocular Therapeutix Was Bumping Higher This Week ↗
March 14, 2025
Via The Motley Fool
News headline image
Ocular Therapeutix Axpaxli Advances In Phase 3 For Wet AMD, Analyst Forecasts Huge Upside ↗
March 11, 2025
Via Benzinga
News headline image
This Primoris Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗
March 11, 2025
Via Benzinga
News headline image
Ocular Therapeutix Stock Sees Worst Day In Nearly A Year On Q4 Miss, But Retail Sees A Comeback ↗
March 03, 2025
Via Stocktwits
News headline image
Earnings Scheduled For March 3, 2025 ↗
March 03, 2025
Via Benzinga

Frequently Asked Questions

Is Ocular Therapeutix, Inc. - Common Stock publicly traded?
Yes, Ocular Therapeutix, Inc. - Common Stock is publicly traded.
What exchange does Ocular Therapeutix, Inc. - Common Stock trade on?
Ocular Therapeutix, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ocular Therapeutix, Inc. - Common Stock?
The ticker symbol for Ocular Therapeutix, Inc. - Common Stock is OCUL on the Nasdaq Stock Market
What is the current price of Ocular Therapeutix, Inc. - Common Stock?
The current price of Ocular Therapeutix, Inc. - Common Stock is 11.82
When was Ocular Therapeutix, Inc. - Common Stock last traded?
The last trade of Ocular Therapeutix, Inc. - Common Stock was at 01/02/26 04:00 PM ET
What is the market capitalization of Ocular Therapeutix, Inc. - Common Stock?
The market capitalization of Ocular Therapeutix, Inc. - Common Stock is 1.86B
How many shares of Ocular Therapeutix, Inc. - Common Stock are outstanding?
Ocular Therapeutix, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap